KENNETH MCCLAIN to Thalidomide
This is a "connection" page, showing publications KENNETH MCCLAIN has written about Thalidomide.
Connection Strength
0.547
-
A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007 Jan; 48(1):44-9.
Score: 0.251
-
Lenalidomide-Dexamethasone as an Effective and?Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and?Pharmacophenomic Study. Am J Hematol. 2026 Jul; 101(7):1478-1483.
Score: 0.238
-
Drug therapy for the treatment of Langerhans cell histiocytosis. Expert Opin Pharmacother. 2005 Nov; 6(14):2435-41.
Score: 0.058